Finance

Beta
Lists
OBAT:IDX
Brigit Biofarmaka Teknologi Tbk PT
IDR 196.00
-0.51%
(-1.00) 1D
Jun 5, 9:37:30 AM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for OBAT...
Open
IDR 197
High
IDR 198
Low
IDR 194
Mkt. cap
133.35B
Avg. vol.
1.97M
Volume
161.90K
Dividend
3.85%
Quarterly dividend
IDR 2
Ex-dividend date
May 22, 2026
P/E ratio
6.24
52-wk high
IDR 580
52-wk low
IDR 191
EPS
IDR 31
Shares outstanding
680.38M
No. of employees
242
Open
IDR 197
High
IDR 198
Low
IDR 194
Mkt. cap
133.35B
Avg. vol.
1.97M
Volume
161.90K
Dividend
3.85%
Quarterly dividend
IDR 2
Ex-dividend date
May 22, 2026
P/E ratio
6.24
52-wk high
IDR 580
52-wk low
IDR 191
EPS
IDR 31
Shares outstanding
680.38M
No. of employees
242
News stories
From sources across the web
About Brigit Biofarmaka Teknologi Tbk PT
CEO-
Employees242
Founded2015
Headquarters-
SectorPersonal care products
Websitebrigit.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
29.01B
47.55B
38.18B
45.37B
Cost of goods sold
15.62B
28.35B
18.76B
35.71B
Cost of revenue
15.62B
28.35B
18.76B
35.71B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.63B
7.79B
7.92B
6.42B
Operating expense
6.34B
7.03B
8.67B
7.08B
Total operating expenses
21.96B
35.37B
27.43B
42.80B
Operating income
7.06B
12.18B
10.75B
2.57B
Other non operating income
-5.02M
12.09M
-54.54M
165.04M
EBT including unusual items
7.10B
11.81B
10.67B
3.27B
EBT excluding unusual items
7.10B
11.81B
10.69B
3.25B
Income tax expense
-
-
4.46B
2.80B
Effective tax rate
-
-
41.86%
85.71%
Other operating expenses
-294.40M
-760.57M
751.69M
660.16M
Net income
6.71B
11.09B
2.38B
2.47B
Net profit margin
23.14%
23.31%
6.22%
5.44%
Earnings per share
-
-
-
-
Interest and investment income
-
-
149.39M
1.36B
Interest expense
-137.12M
-199.01M
-156.33M
-1.34B
Net interest expenses
-137.12M
-199.01M
-6.94M
19.56M
Depreciation and amortization charges
-
-
-
-
EBITDA
7.65B
12.89B
11.71B
2.63B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer